Announcements Trials

Browse Landscape

Phase

Status

Recruiting 2 Active not recruiting 2 Suspended 1 Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Glioma 1 Brain Neoplasms 1

Interventions

Specimen Handling 21 Magnetic Resonance Spectroscopy 18 Carboplatin 17 Gemcitabine 15 Cisplatin 12 pembrolizumab 11 Paclitaxel 11 Injections 11 Interviews as Topic 10 fludarabine 9 Radiotherapy 8 Oxaliplatin 8 Nivolumab 8 Fluorouracil 8 Dexamethasone 8 Cyclophosphamide 8 Irinotecan 7 Bortezomib 7 Biopsy 7 Bevacizumab 7 toripalimab 6 Radiosurgery 6 Pemetrexed 6 Leucovorin 5 Capecitabine 5 130-nm albumin-bound paclitaxel 5 trastuzumab deruxtecan 4 liposomal doxorubicin 4 cemiplimab 4 X-Rays 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × Lomustine × 30 days × Clear all

NCT07629089 2026-06-05

VALIENT

University of Pittsburgh

Phase 1 Not yet recruiting

Brain Neoplasms, Glioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡